Skip to main content

Orthovisc FDA Approval History

FDA Approved: Yes (First approved February 4, 2004)
Brand name: Orthovisc
Generic name: sodium hyaluronate
Dosage form: Injection
Company: Anika Therapeutics, Inc.
Treatment for: Osteoarthritis

Orthovisc is a highly purified, high molecular weight form of hyaluronic acid used for treating pain in patients suffering from osteoarthritis (OA) of the knee who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics.

Development timeline for Orthovisc

Feb  5, 2004Approval Orthovisc Anika Therapeutics, Inc. - Treatment for Osteoarthritis of the Knee

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.